These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 476617

  • 21. Repopulation in murine breast tumors during and after sequential treatments with cyclophosphamide and 5-fluorouracil.
    Wu L, Tannock IF.
    Cancer Res; 2003 May 01; 63(9):2134-8. PubMed ID: 12727830
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS.
    Natl Cancer Inst Monogr; 1978 Dec 01; (49):327-32. PubMed ID: 748788
    [Abstract] [Full Text] [Related]

  • 23. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P, Cerna I.
    Cancer Treat Rep; 1981 Dec 01; 65(1-2):107-14. PubMed ID: 7226161
    [Abstract] [Full Text] [Related]

  • 24. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE, Young RC, Chabner BA.
    Cancer Res; 1976 May 01; 36(5):1653-8. PubMed ID: 1268826
    [Abstract] [Full Text] [Related]

  • 25. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
    Fisher B, Gunduz N.
    J Natl Cancer Inst; 1979 Jun 01; 62(6):1545-51. PubMed ID: 286125
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
    Markaverich BM, Medina D, Clark JH.
    Cancer Res; 1983 Jul 01; 43(7):3208-11. PubMed ID: 6850631
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ, Kerr JA, Daly BM, Evans MJ, Johnke RM.
    Anticancer Res; 1998 Jul 01; 18(3A):1805-12. PubMed ID: 9673408
    [Abstract] [Full Text] [Related]

  • 29. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP, Buffo MJ, Kociban DL.
    Exp Hematol; 1985 Jul 01; 13 Suppl 16():23-30. PubMed ID: 3987836
    [Abstract] [Full Text] [Related]

  • 30. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M, Harada M, Furuichi H, Matsuoka N, Nakano K, Sohmura Y.
    Exp Hematol; 1992 Feb 01; 20(2):161-6. PubMed ID: 1371964
    [Abstract] [Full Text] [Related]

  • 31. Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
    Teicher BA, Holden SA, Cucchi CA, Cathcart KN, Korbut TT, Flatow JL, Frei E.
    Cancer Res; 1988 Jan 01; 48(1):94-100. PubMed ID: 3121169
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK, Lacour F, Hue G.
    Cancer Res; 1982 Nov 01; 42(11):4706-11. PubMed ID: 7127305
    [Abstract] [Full Text] [Related]

  • 33. Effects of double and multiple doses of hydroxyurea on mouse duodenum and mammary tumors.
    Dethlefsen LA, Sorensen SP, Riley RM.
    Cancer Res; 1975 Mar 01; 35(3):694-9. PubMed ID: 1116130
    [Abstract] [Full Text] [Related]

  • 34. Effect of 3,5,3'-triiodo-L-thyronine on the incidence and growth kinetics of spontaneous mammary tumors in C3H/HeN mice.
    Sellitti DF, Tseng YC, Latham KR.
    Cancer Res; 1981 Dec 01; 41(12 Pt 1):5015-9. PubMed ID: 7307003
    [Abstract] [Full Text] [Related]

  • 35. Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin.
    Staroselsky AN, Fan D, O'Brian CA, Bucana CD, Gupta KP, Fidler IJ.
    Cancer Res; 1990 Dec 15; 50(24):7775-80. PubMed ID: 2253220
    [Abstract] [Full Text] [Related]

  • 36. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B, Gebhardt M.
    Cancer Treat Rep; 1978 Nov 15; 62(11):1919-30. PubMed ID: 728912
    [Abstract] [Full Text] [Related]

  • 37. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O, Bissonnette E, Madarnas P, Nigam VN.
    Anticancer Res; 1989 Nov 15; 9(6):1815-8. PubMed ID: 2483306
    [Abstract] [Full Text] [Related]

  • 38. Adriamycin-induced delayed erythropoietic injury expressed following anemia stress.
    Braunschweiger PG, Schenken LL, Schiffer LM.
    Cancer Res; 1980 Jul 15; 40(7):2257-62. PubMed ID: 7388791
    [Abstract] [Full Text] [Related]

  • 39. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors.
    Braunschweiger PG.
    Cancer Res; 1988 Aug 01; 48(15):4206-10. PubMed ID: 3390814
    [Abstract] [Full Text] [Related]

  • 40. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
    Janik P, Briand P, Hartmann NR.
    Cancer Res; 1975 Dec 01; 35(12):3698-704. PubMed ID: 1192428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.